ENG and metastatic malignant neoplasm in the lymph nodes: CD105 expression in OSCC is a promising parameter for assessing the patients at greater risk of recurrent malignancy, lymph node metastasis, and prognosis could bear anti-angiogenic therapeutic potential (Marioni et al., 2010).